BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 25362524)

  • 1. Local Probiotic Therapy for Vaginal Candida albicans Infections.
    Kovachev SM; Vatcheva-Dobrevska RS
    Probiotics Antimicrob Proteins; 2015 Mar; 7(1):38-44. PubMed ID: 25362524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of the association of 2 probiotic strains formulated in a slow release vaginal product, in women affected by vulvovaginal candidiasis: a pilot study.
    Vicariotto F; Del Piano M; Mogna L; Mogna G
    J Clin Gastroenterol; 2012 Oct; 46 Suppl():S73-80. PubMed ID: 22955364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lactobacillus plantarum P17630 for preventing Candida vaginitis recurrence: a retrospective comparative study.
    De Seta F; Parazzini F; De Leo R; Banco R; Maso GP; De Santo D; Sartore A; Stabile G; Inglese S; Tonon M; Restaino S
    Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():136-9. PubMed ID: 25305660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orally administered multispecies probiotic formulations to prevent uro-genital infections: a randomized placebo-controlled pilot study.
    Mezzasalma V; Manfrini E; Ferri E; Boccarusso M; Di Gennaro P; Schiano I; Michelotti A; Labra M
    Arch Gynecol Obstet; 2017 Jan; 295(1):163-172. PubMed ID: 27826653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guideline: vulvovaginal candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis).
    Mendling W; Brasch J; Cornely OA; Effendy I; Friese K; Ginter-Hanselmayer G; Hof H; Mayser P; Mylonas I; Ruhnke M; Schaller M; Weissenbacher ER
    Mycoses; 2015 Mar; 58 Suppl 1():1-15. PubMed ID: 25711406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Probiotic monotherapy of bacterial vaginosis: a open, randomized trial].
    Kovachev S; Dobrevski-Vacheva R
    Akush Ginekol (Sofiia); 2013; 52 Suppl 1():36-42. PubMed ID: 24294744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of a lactobacilli-containing gel on vulvovaginal candidosis and the vaginal microbiome.
    Oerlemans EFM; Bellen G; Claes I; Henkens T; Allonsius CN; Wittouck S; van den Broek MFL; Wuyts S; Kiekens F; Donders GGG; Lebeer S
    Sci Rep; 2020 May; 10(1):7976. PubMed ID: 32409699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14.
    Martinez RC; Franceschini SA; Patta MC; Quintana SM; Candido RC; Ferreira JC; De Martinis EC; Reid G
    Lett Appl Microbiol; 2009 Mar; 48(3):269-74. PubMed ID: 19187507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic activity of a Saccharomyces cerevisiae-based probiotic and inactivated whole yeast on vaginal candidiasis.
    Pericolini E; Gabrielli E; Ballet N; Sabbatini S; Roselletti E; Cayzeele Decherf A; Pélerin F; Luciano E; Perito S; Jüsten P; Vecchiarelli A
    Virulence; 2017 Jan; 8(1):74-90. PubMed ID: 27435998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Combination Fluorescence Assay Demonstrates Increased Efflux Pump Activity as a Resistance Mechanism in Azole-Resistant Vaginal Candida albicans Isolates.
    Bhattacharya S; Sobel JD; White TC
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5858-66. PubMed ID: 27431223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pattern of Candida species isolated from patients with diabetes mellitus and vulvovaginal candidiasis and their response to single dose oral fluconazole therapy.
    Goswami D; Goswami R; Banerjee U; Dadhwal V; Miglani S; Lattif AA; Kochupillai N
    J Infect; 2006 Feb; 52(2):111-7. PubMed ID: 15908007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of sulfur components enhancing the anti-Candida effect of Lactobacillus rhamnosus Lcr35.
    Dausset C; Bornes S; Miquel S; Kondjoyan N; Angenieux M; Nakusi L; Veisseire P; Alaterre E; Bermúdez-Humarán LG; Langella P; Engel E; Forestier C; Nivoliez A
    Sci Rep; 2020 Oct; 10(1):17074. PubMed ID: 33051479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biosurfactant from vaginal Lactobacillus crispatus BC1 as a promising agent to interfere with Candida adhesion.
    De Gregorio PR; Parolin C; Abruzzo A; Luppi B; Protti M; Mercolini L; Silva JA; Giordani B; Marangoni A; Nader-Macías MEF; Vitali B
    Microb Cell Fact; 2020 Jun; 19(1):133. PubMed ID: 32552788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaginal pH and microbiota during fluconazole maintenance treatment for recurrent vulvovaginal candidosis (RVVC).
    Donders GG; Grinceviciene S; Ruban K; Bellen G
    Diagn Microbiol Infect Dis; 2020 Jun; 97(2):115024. PubMed ID: 32253071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoring vaginal microbiota: biological control of bacterial vaginosis. A prospective case-control study using Lactobacillus rhamnosus BMX 54 as adjuvant treatment against bacterial vaginosis.
    Recine N; Palma E; Domenici L; Giorgini M; Imperiale L; Sassu C; Musella A; Marchetti C; Muzii L; Benedetti Panici P
    Arch Gynecol Obstet; 2016 Jan; 293(1):101-107. PubMed ID: 26142892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy of combined 5-nitroimidazole and probiotic therapy of bacterial vaginosis: randomized open trial].
    Kovachev S; Vatcheva-Dobrevski R
    Akush Ginekol (Sofiia); 2013; 52(3):19-26. PubMed ID: 24283058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can Lactobacillus fermentum LF10 and Lactobacillus acidophilus LA02 in a slow-release vaginal product be useful for prevention of recurrent vulvovaginal candidiasis?: A clinical study.
    Murina F; Graziottin A; Vicariotto F; De Seta F
    J Clin Gastroenterol; 2014; 48 Suppl 1():S102-5. PubMed ID: 25291115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility to some antifungal drugs of vaginal lactobacilli isolated from healthy women.
    Kilic E; Aslim B; Taner Z
    Drug Metabol Drug Interact; 2005; 21(1):67-74. PubMed ID: 16086557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pulsatilla decoction inhibits vulvovaginal Candida albicans proliferation and reduces inflammatory cytokine levels in vulvovaginal candidiasis mice].
    Xia D; Zhang M; Shi G; Xu Z; Wu D; Shao J; Wang T; Wang C
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Feb; 32(2):153-7. PubMed ID: 26927371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Vitro Activity of Tea Tree Oil Vaginal Suppositories against Candida spp. and Probiotic Vaginal Microbiota.
    Di Vito M; Mattarelli P; Modesto M; Girolamo A; Ballardini M; Tamburro A; Meledandri M; Mondello F
    Phytother Res; 2015 Oct; 29(10):1628-33. PubMed ID: 26235937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.